Krishna Kodukula's Biography

Krishna Kodukula, Executive Director, CADRE, SRI International

Krishna Kodukula, Ph.D., is executive director, strategic development and site head of SRI Shenandoah Valley in Harrisonburg, Virginia. Prior to that, he was executive director of SRI’s Center for Advanced Drug Research, and co-leader of drug discovery in SRI Biosciences.

Kodukula joined SRI from Sarnoff Corporation (an SRI subsidiary at the time that has now been integrated into SRI). While at Sarnoff, he was the technical lead of a national program for reducing the time to discover and develop new drugs during a national emergency. At SRI, Kodukula is establishing new programs and expanding business opportunities, with a focus on practical applications of the science of proteomics.

Prior to Sarnoff, Kodukula helped launch Small Molecule Therapeutics, a drug discovery start-up in the Princeton, New Jersey area, and co-found Pyxis Technology Solutions, an IT tools developer based in India and in the United States. Previously, he was a senior research investigator at Bristol-Myers Squibb Pharmaceutical Research Institute and a fellow at the Roche Institute of Molecular Biology, Hoffman-La Roche. Kodukula has a Ph.D. in biochemistry and botany from Utkal University, Bhubaneswar in India, and did postdoctoral work at the Indian Institute of Science, where he was a National Biotechnology Board fellow.

Kodukula has more than 30 years of experience in conducting basic and industrial research focused on discovering new therapies for globally important diseases such as cancer, metabolic and neurological disorders.Presently, Dr. Kodukula is interested in a holistic understanding of biological function and discovering novel biomarkers for different diseases. Over the past 15 years, in addition to leading research groups, he has helped launch several new companies, and license many inventions and technologies for commercialization through external partnerships.